Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
National Institutes of Health · National Cancer Institute · +4 more institutions
Abstract
Stem-like T cells mediate response Adoptive cell transfer (ACT) is a type of immunotherapy that uses a patient's own T lymphocytes to recognize and attack cancer. ACT has been effective in treating certain patients with metastatic melanoma and is being applied to treat some epithelial cancers. Krishna et al. investigated why some cancer patients respond to ACT, whereas others do not. They identified a population of CD8 + T cells that had stem-like surface markers that were associated with effective tumor cell killing and favorable response of melanoma patients to ACT. Only a small subset of T cells specific against tumor mutations were found in this stem-like state, whereas most mutation-reactive T cells were…
Citation impact
- FWCI
- 24.28
- Percentile
- 100%
- References
- 66
Authors
22- SKSri KrishnaCorresponding
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- FJFrank J. LoweryCorresponding
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- ARAmy R. Copeland
National Institutes of Health, National Cancer Institute, Center for Cancer Research
- EBErol Bahadiroglu
National Cancer Institute
- RMRatnadeep Mukherjee
National Cancer Institute
Topics & keywords
- Adoptive cell transfer
- Adoptive immunotherapy
- CD8
- Immunotherapy
- Immunology
- Phenotype
- Ex vivo
- Progenitor cell
- No poverty